Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1990-01-24
1992-01-14
Lee, Lester L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 18, C07K 506, C07K 508
Patent
active
050811088
ABSTRACT:
Purified human leukocyte dialysates are described for treatment of AIDS, ARC, and other immunodeficient conditions. The dialysates are purified by HPLC processes, and are made available in a form that is free of endotoxin and pyrogen. Methods are described for slowing the progression from ARC to AIDS and for alleviating symptoms of AIDS and ARC, by administration of the dialysates. Methods for treating candidiasis and for increasing immune system response to recall antigen, by administration of the dialysates, are also described.
REFERENCES:
Talmadge et al. 13th Internatl. Congress of Chemotherapy, 1983, pp. 203/19-203/35.
Imreg, Inc.
Lee Lester L.
Maebius Stephen B.
Stern Richard H.
LandOfFree
Method of showing progression of AIDS in an ARC patient by treat does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of showing progression of AIDS in an ARC patient by treat, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of showing progression of AIDS in an ARC patient by treat will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-541694